PHA-665752

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NamePHA-665752
Drug Alias NamePHA-665752
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action +[1]  N/A
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSugen Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSugen Llc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A